ABBOTINDIA

Abbott India Share Price

 

 

Invest in Abbott India with 3.77X leverage

Invest with MTF

Performance

  • Low
  • ₹28,660
  • High
  • ₹29,140
  • 52 Week Low
  • ₹25,325
  • 52 Week High
  • ₹37,000
  • Open Price₹28,850
  • Previous Close₹28,850
  • Volume8,644

Investment Returns

  • Over 1 Month -1.41%
  • Over 3 Month -7.08%
  • Over 6 Month -8.68%
  • Over 1 Year -0.33%

Smart Investing Starts Here Start SIP with Abbott India for Steady Growth!

Invest Now

Abbott India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 40.8
  • PEG Ratio
  • 2.3
  • Market Cap Cr
  • 61,506
  • P/B Ratio
  • Average True Range
  • 632.71
  • EPS
  • 710.09
  • Dividend Yield
  • 1.6
  • MACD Signal
  • -98.92
  • RSI
  • 40.87
  • MFI
  • 28.62

Abbott India Financials

Abbott India Technicals

EMA & SMA

Current Price
₹28,945.00
+ 95 (0.33%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹29,467.37
  • 50 Day
  • ₹29,887.98
  • 100 Day
  • ₹30,438.39
  • 200 Day
  • ₹30,439.50

Resistance and Support

28915 Pivot Speed
  • R3 29,650.00
  • R2 29,395.00
  • R1 29,170.00
  • S1 28,690.00
  • S2 28,435.00
  • S3 28,210.00

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Abbott India Ltd., develops, manufactures, and sells pharmaceutical products across women's health, gastroenterology, cardiology, metabolic disorders, and primary care. A key player in India’s healthcare sector, Abbott operates with a focus on quality and innovation.

Abbott India has an operating revenue of Rs. 6,714.37 Cr. on a trailing 12-month basis. An annual revenue growth of 10% is good, Pre-tax margin of 29% is great, ROE of 33% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 81 which is a GOOD score indicating consistency in earnings, a RS Rating of 50 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 66 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Abbott India Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-06 Quarterly Results
2025-08-12 Quarterly Results
2025-05-15 Audited Results & Final Dividend
2025-02-05 Quarterly Results
2024-11-07 Quarterly Results
Date Purpose Remarks
2025-07-25 FINAL Rs.475.00 per share(4750%)Final Dividend
2024-07-19 FINAL Rs.410.00 per share(4100%)Final Dividend
2023-07-21 FINAL Rs.180.00 per share(1800%)Final Dividend
2023-07-21 SPECIAL Rs.145.00 per share(1450%)Special Dividend
View Abbott India Dividend History Arrow

Abbott India F&O

Abbott India Shareholding Pattern

74.99%
7.78%
1.05%
0.16%
0.02%
13.43%
2.57%

About Abbott India

  • NSE Symbol
  • ABBOTINDIA
  • BSE Symbol
  • 500488
  • Managing Director
  • Mr. Kartik Rajendran
  • ISIN
  • INE358A01014

Similar Stocks to Abbott India

Abbott India FAQs

Abbott India share price is ₹28,945 As on 06 December, 2025 | 10:19

The Market Cap of Abbott India is ₹61506.1 Cr As on 06 December, 2025 | 10:19

The P/E ratio of Abbott India is 40.8 As on 06 December, 2025 | 10:19

The PB ratio of Abbott India is 14.5 As on 06 December, 2025 | 10:19

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23